Sen. Susan M. Collins sold Gilead Sciences (GILD)
Sen. Susan M. Collins (R-ME) · $1K–$15K · traded Apr 14, 2014
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Apr 14, 2014
- Disclosed
- Jul 20, 2015
- Days to disclose
- 462 (after the 45-day deadline)
- Asset type
- Stock
- As filed
- Gilead Sciences Inc. (NASDAQ)
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Jul 20, 2015$1K–$15K
Bought American Express Company AXP
$1K–$15K · Traded Apr 23, 2014 · disclosed Jul 20, 2015 · Spouse · filed 453 days later
Got $8K from the company’s PAC - Jul 20, 2015$1K–$15K
Sold (partial) The Goldman Sachs Group GS
$1K–$15K · Traded Apr 23, 2014 · disclosed Jul 20, 2015 · Spouse · filed 453 days later
Got $5K from the company’s PAC - Jul 20, 2015$1K–$15K
Sold (partial) Bank of America BAC
$1K–$15K · Traded Apr 22, 2014 · disclosed Jul 20, 2015 · Spouse · filed 454 days later
Got $5K from the company’s PAC - Jul 20, 2015$1K–$15K
$1K–$15K · Traded Apr 22, 2014 · disclosed Jul 20, 2015 · Spouse · filed 454 days later
- Jul 20, 2015$1K–$15K
Bought The Charles Schwab SCHW
$1K–$15K · Traded Apr 21, 2014 · disclosed Jul 20, 2015 · Spouse · filed 455 days later
- Jul 20, 2015$1K–$15K
$1K–$15K · Traded Apr 17, 2014 · disclosed Jul 20, 2015 · Spouse · filed 459 days later
- Jul 20, 2015$1K–$15K
Bought Arthur J. Gallagher & AJG
$1K–$15K · Traded Apr 15, 2014 · disclosed Jul 20, 2015 · Spouse · filed 461 days later
- Jul 20, 2015$1K–$15K
$1K–$15K · Traded Apr 11, 2014 · disclosed Jul 20, 2015 · Spouse · filed 465 days later
- Jul 20, 2015$1K–$15K
Sold (partial) Liberty Global LBTYK
$1K–$15K · Traded Apr 10, 2014 · disclosed Jul 20, 2015 · Spouse · filed 466 days later
- Jul 20, 2015$1K–$15K
Sold (partial) Liberty Global LBTYA
$1K–$15K · Traded Apr 10, 2014 · disclosed Jul 20, 2015 · Spouse · filed 466 days later
- Jul 20, 2015$1K–$15K
$1K–$15K · Traded Apr 10, 2014 · disclosed Jul 20, 2015 · Spouse · filed 466 days later
Got $8K from the company’s PAC - Jul 20, 2015$1K–$15K
$1K–$15K · Traded Apr 10, 2014 · disclosed Jul 20, 2015 · Spouse · filed 466 days later
- Jul 20, 2015$1K–$15K
Sold (partial) Lowe's Companies LOW
$1K–$15K · Traded Apr 10, 2014 · disclosed Jul 20, 2015 · Spouse · filed 466 days later
- Jul 20, 2015$1K–$15K
$1K–$15K · Traded Apr 10, 2014 · disclosed Jul 20, 2015 · Spouse · filed 466 days later
Recent Congress trades in GILD
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026
- Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026 · Dependent
- Feb 26, 2026$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jan 27, 2026 · disclosed Feb 26, 2026 · Joint
- Oct 10, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Sep 23, 2025 · disclosed Oct 10, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 12, 2025 · disclosed Jun 22, 2025
- Jun 18, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Jun 6, 2025 · disclosed Jun 18, 2025
Company context for GILD
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
GILD: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
GILD: Financial results
Filed 8-K for an event or period dated 2026-10-29. Financial results.
GILD: third_quarter 2026 lobbying report
Advocate on domestic and global drug pricing proposals, international trade and protection of intellectual property; global supply chain issues, including the Medical Supply Chain Resiliency Act and tariffs; compulsory licensing and other IP issues in multiple countries. Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals. Advocate on drug pricing proposals. Proposals to exp
Public: Oct 21, 2026, 1:36 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.